DOCSLIB.ORG

Integrative Analysis of the Cancer Transcriptome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Integrative Analysis of the Cancer Transcriptome PERSPECTIVE Integrative analysis of the cancer transcriptome Daniel R Rhodes & Arul M Chinnaiyan DNA microarrays have been widely applied to the study of making a list of differences in the parts and then focusing on a single human cancer, delineating myriad molecular subtypes of part. Opposite to this single-part approach, a new line of attack seeks cancer, many of which are associated with distinct biological to examine the cancer profile as a whole, often in the context of other underpinnings, disease progression and treatment response. cancer signatures or other types of genomic data. Such integrative These primary analyses have begun to decipher the molecular approaches are capable of simplifying complex cancer signatures heterogeneity of cancer, but integrative analyses that evaluate into coordinately regulated modules, transforming one-dimensional http://www.nature.com/naturegenetics cancer transcriptome data in the context of other data sources cancer signatures into multidimensional interaction networks and are often capable of extracting deeper biological insight from extracting regulatory mechanisms encoded in cancer gene expres- the data. Here we discuss several such integrative computational sion. Here, we review approaches that glean biological insight from and analytical approaches, including meta-analysis, functional cancer microarray data by applying integrative computational and enrichment analysis, interactome analysis, transcriptional analytical methodologies. network analysis and integrative model system analysis. Before exploring the integrative analyses carried out on cancer tran- scriptome data, it is useful to provide a brief overview of the cancer The widespread application of DNA microarrays to cancer research is profiling field. In the past few years, we have witnessed an explosion nothing less than astounding. In the short ten-year history of this ver- of cancer profiling studies. Once a technology available in only a few satile technology, hundreds of large-scale experiments have been done, laboratories, DNA microarrays now seem as pervasive as PCR. generating global quantitative profiles of gene expression in cancer. Querying the Affymetrix database of publications for all reports relat- Known types and subtypes of cancer have been readily distinguished by ing to human cancer returned 646 primary research articles, 453 of their gene-expression patterns, and more importantly, new molecular which were published in the last two years. GEO (Gene Expression 2005 Nature Publishing Group Group 2005 Nature Publishing © subtypes of cancer have been discovered that are associated with a host Omnibus), which has emerged as one of the principal repositories of tumor properties, including the propensity to metastasize and sensi- for microarray data4,5, returned 84 data sets when queried for ‘Homo tivity or resistance to particular therapies. The clinical utility of array- sapiens’ and ‘cancer.’ The Oncomine database (http://www.oncomine. based gene profiles is evidenced by recent studies showing that cancer org/)6, which includes data sets that have profiled ten or more human gene-expression signatures may affect clinical decision-making in breast tumor samples (excluding cell line studies), has catalogued 300 primary cancer and lymphoma management1,2. It may not be long before every research articles and amassed 114 data sets, totaling > 8,000 microarray human cancer sample is profiled with a gene chip to ascertain a molecu- experiments, each profiling a distinct human tissue sample. From this lar diagnosis and prognosis and to define an optimal treatment strategy. large body of cancer gene-expression research, several themes have Before this becomes a reality, however, careful validation to identify emerged. First, cancer types can be reliably distinguished from nor- optimal signatures is needed3. Apart from the impact of microarrays mal tissue of the same type based on global gene-expression patterns. on clinical decision-making, cancer microarray profiling is also poised Second, predominant clinical and pathological subtypes of cancer to advance our understanding of cancer biology and, ultimately, aid in often have distinct gene-expression profiles. Third, gene-expression the development of new and more effective therapies. signatures of primary tumors can often predict disease recurrence, The biologist’s initial instinct might be to use cancer microarray distant metastasis, survival and treatment response. Fourth, hetero- data as a prioritized list of candidate genes for experimental work-up, geneous cancers can be subclassified into molecular subtypes on the hoping to strike gold and identify a gene important in cancer among basis of gene-expression signatures7. These results were generated with a sizeable differential expression profile. Although this approach has primary analytical methods such as hierachical clustering8 and statis- identified several genes important in cancer, it is akin to asking what tically based differential expression analysis9,10, usually with careful makes an airplane different from an automobile, taking both apart, consideration for multiple-hypothesis testing11. Although these primary analyses have made great strides in deci- phering the complex molecular heterogeneity of cancer, integrative Daniel R. Rhodes is in the Departments of Pathology and Bioinformatics and the Comprehensive Cancer Center, and Arul M. Chinnaiyan is in the Departments of bioinformatics approaches that leverage multiple types of informa- Pathology, Bioinformatics and Urology and the Comprehensive Cancer Center at tion have begun to show promise in uncovering important biology the University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. not apparent from standard analysis methods (i.e., differential expres- e-mail: [email protected] sion analysis, hierarchical clustering, etc.). We highlight several such Published online 26 May 2005; doi:10.1038/ng1570 approaches, including meta-analysis for extracting robust profiles from NATURE GENETICS SUPPLEMENT| VOLUME 37 | JUNE 2005 S31 PERSPECTIVE a b Meta-analysis of cancer signatures With hundreds of cancer signatures published Cancer gene-expression profiling with DNA microarrays in the literature, several types of integrative Tissue mRNA Microarray Gene expression analysis can be done. We call analysis of mul- hybridization dataset tiple data sets ‘meta-analyses,’ similar to meta- Samples analyses done in clinical research, in which multiple studies interrogating a common Genes hypothesis are analyzed together. In the realm Lung adenocarcinoma Small cell lung cancer Hepatocellular carcinoma carcinoma Ovarian Colon carcinoma Prostate carcinoma Breast ductal carcinoma Salivary carcinoma Glioma Medulloblastoma carcinoma Pancreatic Bladder carcinoma Diffuse large B cell lymphoma Gene of microarray data, meta-analysis is compli- NME1 TOP2A ** cated by distinct experimental platforms and ARMET Data collection, E2F5 ** designs, and so gene-expression measurements Collection of cancer microarray data processing, ACLY normalization PAICS 40 independent data sets, 15 cancer types PRDX4 are not always directly comparable. Several 3,762 microarray experiments IARS p100 studies have applied meta-analysis methods 37,901,459 gene expression measurements HNRPA2B1 SOX4 ** COPB2 to cancer microarray data, both to identify SMARCA4 SSBP1 robust gene-expression signatures in a single TSTA3 SSR1 cancer type and to look for common expres- CKS2 PLK ** ILF2 sion patterns across different types of cancer. Differential expression analysis SNRPE KPNA2 We applied a summary statistic-based method Sample class Student's t-test for P values Q values NONO HSPD1 coupled with false discovery rate analysis to assignment each gene OK/SW-cl.56 CANX Mean 1 = 0.52 CCT5 compare four gene-expression studies that Mean 2 = 1.81 OGT T statistic = 2.85 HSPE1 P value = 0.02 analyzed clinically localized prostate cancer TRAF4 Genes Genes MTHFD2 relative to benign prostate tissue and identi- KDELR2 SDHC http://www.nature.com/naturegenetics E2-EPF fied a signature of genes commonly activated SNRPF G3BP in prostate cancer across all data sets, irrespec- AHCY 13 81 differential expression analyses from 34 data sets TARS tive of technological platform . After defin- PAFAH1B3 PTMA ing a robust signature for prostate cancer, we Metaprofiling RBM4 PSME2 ** TRA1 carried out pathway analysis with the KEGG Differential expression Significance threshold Identify genes most CRIP2 14 analysis selection to define signatures enriched in signatures PSMA1b** database and found that the polyamine bio- CDKN3 CDC2 ** Gene Count MRPL3 synthesis pathway was hyperactivated, consis- H2AFX 5 RFC4 PSMC4 ** Genes EZH2 5 tent with the known elevation of polyamines DVL3 BIRC5 5 .... C7orf14 in prostate cancer. Another report identified MCM3 ** FAP Compare gene enrichment Define 'metasignature' Assess robustness TGIF gene expression–based classes of breast cancer in signatures with a random if significant gene of metasignature KIAA0111 LDHA simulation enrichment by leave-one-out in one data set and then searched for the exis- IFNGR2 (mFDRMIN < 0.10) class prediction KIAA0101 tence of the classes in two independent data MMP9 ** HDAC1 sets15. Three main biological subtypes held 2005 Nature Publishing Group Group 2005 Nature Publishing CBX3 CCT4 © COL1A2 up in the two independent datasets: basal- Genes (#) Genes MRPS12 NCBP2 like, ERBB2-overexpressing and luminal- PPP2R5C 0 1 2 3 4 5 C20orf1 Signatures (#) like, reflecting
Load more

Recommended publications
  • A Cell Line P53 Mutation Type UM
    A Cell line p53 mutation Type UM-SCC 1 wt UM-SCC5 Exon 5, 157 GTC --> TTC Missense mutation by transversion (Valine --> Phenylalanine UM-SCC6 wt UM-SCC9 wt UM-SCC11A wt UM-SCC11B Exon 7, 242 TGC --> TCC Missense mutation by transversion (Cysteine --> Serine) UM-SCC22A Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC22B Exon 6, 220 TAT --> TGT Missense mutation by transition (Tyrosine --> Cysteine) UM-SCC38 Exon 5, 132 AAG --> AAT Missense mutation by transversion (Lysine --> Asparagine) UM-SCC46 Exon 8, 278 CCT --> CGT Missense mutation by transversion (Proline --> Alanine) B 1 Supplementary Methods Cell Lines and Cell Culture A panel of ten established HNSCC cell lines from the University of Michigan series (UM-SCC) was obtained from Dr. T. E. Carey at the University of Michigan, Ann Arbor, MI. The UM-SCC cell lines were derived from eight patients with SCC of the upper aerodigestive tract (supplemental Table 1). Patient age at tumor diagnosis ranged from 37 to 72 years. The cell lines selected were obtained from patients with stage I-IV tumors, distributed among oral, pharyngeal and laryngeal sites. All the patients had aggressive disease, with early recurrence and death within two years of therapy. Cell lines established from single isolates of a patient specimen are designated by a numeric designation, and where isolates from two time points or anatomical sites were obtained, the designation includes an alphabetical suffix (i.e., "A" or "B"). The cell lines were maintained in Eagle's minimal essential media supplemented with 10% fetal bovine serum and penicillin/streptomycin.
    [Show full text]
  • UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The
    UNIVERSITY OF CALIFORNIA RIVERSIDE Investigations into the Role of TAF1-mediated Phosphorylation in Gene Regulation A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Cell, Molecular and Developmental Biology by Brian James Gadd December 2012 Dissertation Committee: Dr. Xuan Liu, Chairperson Dr. Frank Sauer Dr. Frances M. Sladek Copyright by Brian James Gadd 2012 The Dissertation of Brian James Gadd is approved Committee Chairperson University of California, Riverside Acknowledgments I am thankful to Dr. Liu for her patience and support over the last eight years. I am deeply indebted to my committee members, Dr. Frank Sauer and Dr. Frances Sladek for the insightful comments on my research and this dissertation. Thanks goes out to CMDB, especially Dr. Bachant, Dr. Springer and Kathy Redd for their support. Thanks to all the members of the Liu lab both past and present. A very special thanks to the members of the Sauer lab, including Silvia, Stephane, David, Matt, Stephen, Ninuo, Toby, Josh, Alice, Alex and Flora. You have made all the years here fly by and made them so enjoyable. From the Sladek lab I want to thank Eugene, John, Linh and Karthi. Special thanks go out to all the friends I’ve made over the years here. Chris, Amber, Stephane and David, thank you so much for feeding me, encouraging me and keeping me sane. Thanks to the brothers for all your encouragement and prayers. To any I haven’t mentioned by name, I promise I haven’t forgotten all you’ve done for me during my graduate years.
    [Show full text]
  • B Inhibition in a Mouse Model of Chronic Colitis1
    The Journal of Immunology Differential Expression of Inflammatory and Fibrogenic Genes and Their Regulation by NF-␬B Inhibition in a Mouse Model of Chronic Colitis1 Feng Wu and Shukti Chakravarti2 Fibrosis is a major complication of chronic inflammation, as seen in Crohn’s disease and ulcerative colitis, two forms of inflam- matory bowel diseases. To elucidate inflammatory signals that regulate fibrosis, we investigated gene expression changes under- lying chronic inflammation and fibrosis in trinitrobenzene sulfonic acid-induced murine colitis. Six weekly 2,4,6-trinitrobenzene sulfonic acid enemas were given to establish colitis and temporal gene expression patterns were obtained at 6-, 8-, 10-, and 12-wk time points. The 6-wk point, TNBS-w6, was the active, chronic inflammatory stage of the model marked by macrophage, neu- trophil, and CD3؉ and CD4؉ T cell infiltrates in the colon, consistent with the idea that this model is T cell immune response driven. Proinflammatory genes Cxcl1, Ccl2, Il1b, Lcn2, Pla2g2a, Saa3, S100a9, Nos2, Reg2, and Reg3g, and profibrogenic extra- cellular matrix genes Col1a1, Col1a2, Col3a1, and Lum (lumican), encoding a collagen-associated proteoglycan, were up-regulated at the active/chronic inflammatory stages. Rectal administration of the NF-␬B p65 antisense oligonucleotide reduced but did not abrogate inflammation and fibrosis completely. The antisense oligonucleotide treatment reduced total NF-␬B by 60% and down- regulated most proinflammatory genes. However, Ccl2, a proinflammatory chemokine known to promote fibrosis, was not down- regulated. Among extracellular matrix gene expressions Lum was suppressed while Col1a1 and Col3a1 were not. Thus, effective treatment of fibrosis in inflammatory bowel disease may require early and complete blockade of NF-␬B with particular attention to specific proinflammatory and profibrogenic genes that remain active at low levels of NF-␬B.
    [Show full text]
  • Spectrum of Chromosomal Aberrations in Peripheral Blood Lymphocytes of Gastrointestinal Tract (GIT) and Breast Cancer Patients
    © Kamla-Raj 2010 Int J Hum Genet, 10(1-3): 147-158 (2010) Spectrum of Chromosomal Aberrations in Peripheral Blood Lymphocytes of Gastrointestinal Tract (GIT) and Breast Cancer Patients Kamlesh Guleria and Vasudha Sambyal Department of Human Genetics, Guru Nanak Dev University, Amritsar 143 005, Punjab, India KEYWORDS Peripheral Blood Lymphocytes. Gastrointestinal Cancer. Breast Cancer. Chromosomal Aberrations ABSTRACT The aim of present study was to assess the spectrum of chromosomal aberrations in peripheral blood lymphocytes of sporadic Gastrointestinal tract (GIT) and Breast cancer patients. Ninety eight patients (56 GIT cancer and 42 breast cancer) and seventy seven unrelated healthy set of control individuals were investigated in the present study. Lymphocytes were cultured using standard protocol. In each case, 100 metaphases were screened for numerical as well as structural aberrations. Higher frequency of aberrant metaphases with chromosomal aberrations including gaps, breaks, terminal deletions, acentric fragments, double minutes, acrocentric associations, premature chromatid separations, pulverisations, polyploidy, loss and gain of chromosomes, ring chromosome and marker chromosomes were observed in cancer patients as compared to controls. A non-random involvement in aberrations of chromosomes harbouring genes implicated in tumorigenesis was observed in GIT as well as in breast cancer patients. Aberrations in peripheral blood lymphocytes (PBLs) can indicate the constitutional anomalies and understanding of molecular basis of chromosomal instability (CIN) phenotype can help in earlier diagnosis or prognosis. INTRODUCTION typic changes that contribute to tumor cell evolution and pose therapeutic challenges (Gao Genomic instability is a prerequisite for the et al. 2007). Defects in both bipolar spindle onset of cancer. The majority of cancer cells are assembly and the spindle assembly checkpoint aneuploid, representing dynamic karyotypic have been identified in some CIN tumor cell lines changes, including gain or loss of whole chromo- (Cahill et al.
    [Show full text]
  • Molecular Pathogenesis of Endometriosis-Associated Clear Cell Carcinoma of the Ovary (Review)
    233-240.qxd 22/6/2009 11:19 Ì ™ÂÏ›‰·233 ONCOLOGY REPORTS 22: 233-240, 2009 233 Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review) HIROSHI KOBAYASHI, HIROTAKA KAJIWARA, SEIJI KANAYAMA, YOSHIHIKO YAMADA, NAOTO FURUKAWA, TAKETOSHI NOGUCHI, SHOJI HARUTA, SHOZO YOSHIDA, MARIKO SAKATA, TOSHIYUKI SADO and HIDEKAZU OI Department of Obstetrics and Gynecology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Japan Received February 10, 2009; Accepted April 29, 2009 DOI: 10.3892/or_00000429 Abstract. Epithelial ovarian cancer (EOC) is the leading Contents cause of death in women with gynecological malignancies. Among EOC, clear cell carcinoma (CCC) and endometrioid 1. Introduction adenocarcinoma (EAC) differ from the other histological 2. Identification of relevant studies types with respect to their clinical characteristics and 3. Characteristics of CCC carcinogenesis. Both tumor types are often associated with 4. LOH analysis endometriosis. EAC is recently reported to be characterized 5. LOH involved in endometrioid adenocarcinoma (EAC) of by K-RAS activation and PTEN dysfunction. However, the the ovary molecular changes in CCC remain largely unknown. The aim 6. LOH involved in clear cell carcinoma (CCC) of the ovary: of this review is to summarize the current knowledge on the the candidate tumor suppressor genes molecular mechanisms involved in CCC tumorigenesis. The 7. Microsatellite instability in CCC present article reviews the English language literature for 8. Genes specifically up-regulated in CCC biological, pathogenetic and pathophysiological studies on 9. Clear cell adenofibroma-CCC sequence endometriosis-associated CCC of the ovary. Several recent 10. Iron, oxidative stress and carcinogenesis studies of loss of heterozygosity (LOH), allelic loss, com- 11.
    [Show full text]
  • An Ancient Deletion in the ABO Gene Affects the Composition of the Porcine Microbiome by Altering Intestinal N-Acetyl-Galactosam
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.16.206219; this version posted July 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Effect of the ABO locus on the porcine gut microbiome Page 1 of 66 1 An ancient deletion in the ABO gene affects the composition of the porcine microbiome 2 by altering intestinal N-acetyl-galactosamine concentrations. 3 Hui Yang1*, Jinyuan Wu1*, Xiaochang Huang1, Yunyan Zhou1, Yifeng Zhang1, Min Liu1, Qin Liu1, 4 Shanlin Ke1, Maozhang He1, Hao Fu1, Shaoming Fang1, Xinwei Xiong1, Hui Jiang1, Zhe Chen1, 5 Zhongzi Wu1, Huanfa Gong1, Xinkai Tong1, Yizhong Huang1, Junwu Ma1, Jun Gao1, Carole 6 Charlier2,1, Wouter Coppieters2,1, Lev Shagam2, Zhiyan Zhang1, Huashui Ai1, Bin Yang1, Michel 7 Georges2,1,$ ,† , Congying Chen1, $,†, Lusheng Huang1, $,†,#. 8 1National Key Laboratory for Swine genetic improvement and production technology, 9 Ministry of Science and Technology of China, Jiangxi Agricultural University, NanChang, Jiangxi 10 Province, 330045, PR China. 2Unit of Animal Genomics, GIGA-Institute and Faculty of 11 Veterinary Medicine, University of Liege, 4000 Liege, Belgium. 12 *Contributed equally to this work. $Senior authors. †Corresponding authors. #Lead contact. 13 14 Summary 15 We have generated a large heterogenous stock population by intercrossing eight divergent 16 pig breeds for multiple generations. We have analyzed the composition of the intestinal 17 microbiota at different ages and anatomical locations in > 1,000 6th- and 7th- generation 18 animals. We show that, under conditions of exacerbated genetic yet controlled 19 environmental variability, microbiota composition and abundance of specific taxa (including 20 Christensenellaceae) are heritable in this monogastric omnivore.
    [Show full text]
  • Stem Cell-Based Reporter Assays for the Identification of Carcinogenic Properties of (Non)-Genotoxic Chemicals
    UNIVERSIDADE DE LISBOA Faculdade de Ciências Departamento de Biologia Animal Stem cell-based reporter assays for the identification of carcinogenic properties of (non)-genotoxic chemicals Cátia Sofia Alão Gonçalves DISSERTAÇÃO MESTRADO EM BIOLOGIA HUMANA E AMBIENTE 2013 UNIVERSIDADE DE LISBOA Faculdade de Ciências Departamento de Biologia Animal Stem cell-based reporter assays for the identification of carcinogenic properties of (non)-genotoxic chemicals Cátia Sofia Alão Gonçalves Dissertação orientada por: Dr. Harry Vrieling (Toxicogenetic/LUMC) Professora Dra. Deodália Dias (DBA/FCUL) DISSERTAÇÃO MESTRADO EM BIOLOGIA HUMANA E AMBIENTE 2013 Acknowledgements First of all I would like to express my deep and sincere gratitude to Harry Vrieling, for having welcomed me in your workgroup and give me the opportunity to develop my dissertation. I also have to thank Giel Hendriks for the useful discussions and uplifting spirits that allowed me to develop my dissertation and allowed me to develop, not only the professional level, but also the personal one. A special thanks to the entire lab, in particular to Brunno for helping me with the BAC recombennering and the great talks, to Fabienne for the tips on how to culture the mES cell lines and for her constant assistance in the Lab and to Binni for helping me understand a little better the Dutch culture. I wish to thank all of my colleagues at the Department of Toxicogenetics, at the Leiden University Medical Centre, for all the support. I thank Professor Deodália Dias for all the support provided under this thesis and also in my training. I want to thank to all the friends that I made during my time in Leiden, without them, probably this dissertation would not be completed.
    [Show full text]
  • Dissection of Prostate Tumour, Stroma and Immune Transcription Reveals a Key Contribution by the Microenvironment to Disease Progression
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.16.993162; this version posted March 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dissection of prostate tumour, stroma and immune transcription reveals a key contribution by the microenvironment to disease progression Stefano Mangiola1,2,3, Patrick McCoy2,3, Martin Modrak4, Fernando Souza-Fonseca-Guimaraes5, Daniel Blashki7, Ryan Stuchbery3, Michael Kerger8, Ken Chow2,3, Chayanica Nasa9, Melanie Le Page9, Natalie Lister10, Simon Monard9, Justin Peters8, Phil Dundee8, Anthony J. Costello2,3,8, Bhupinder Pal11, Nicholas D. Huntington5, Niall M. Corcoran2,3,8,12,*, Anthony T. Papenfuss1,13,14,15,16,*, Christopher M. Hovens2,3,8,* 1Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia 2Department of Surgery, The University of Melbourne, Parkville, Victoria, Australia 3Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia 4Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic. 5Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia 6University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australia 7The Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia 8Australian Prostate Cancer Research Centre
    [Show full text]
  • Functions for the Cardiomyokine, MANF, in Cardioprotection, Hypertrophy and Heart Failure
    Journal of Molecular and Cellular Cardiology 51 (2011) 512–517 Contents lists available at ScienceDirect Journal of Molecular and Cellular Cardiology journal homepage: www.elsevier.com/locate/yjmcc Review Article Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure Christopher C. Glembotski ⁎ The SDSU Heart Institute and the Department of Biology, San Diego State University, San Diego, CA 92182, USA article info abstract Article history: We define cardiomyokines as heart-derived secreted proteins that affect cardiovascular function via Received 5 August 2010 autocrine, paracrine and/or endocrine mechanisms. The subject of this review is the cardiomyokine, Received in revised form 1 October 2010 mesencephalic astrocyte-derived neurotrophic factor (MANF). The expression of MANF is increased in the Accepted 4 October 2010 ischemic heart, in part, through activation of ER stress, a condition that drastically impairs the expression and Available online 21 October 2010 secretion of most cardiomyokines. This novel function of MANF suggests that it may have important roles in the ER stressed, ischemic heart. Consistent with this are recent findings showing that MANF protects against Keywords: Cardiomyokine ischemic damage, and that it is anti-hypertrophic. Accordingly, in light of its function as a potentially secreted MANF cardiomyokine, MANF has translational potential as a novel therapy for ischemic heart disease. This article is ER stress part of a special issue entitled “Key Signaling Molecules in Hypertrophy and Heart Failure.” Cardioprotection © 2010 Elsevier Ltd. All rights reserved. Hypertrophy Contents 1. Introduction .............................................................. 512 1.1. Cardiomyokines and ER stress .................................................. 512 1.2. MANF, an ATF6-regulated gene in the heart ...........................................
    [Show full text]
  • ARMET (MANF) (NM 006010) Human Untagged Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for SC122734 ARMET (MANF) (NM_006010) Human Untagged Clone Product data: Product Type: Expression Plasmids Product Name: ARMET (MANF) (NM_006010) Human Untagged Clone Tag: Tag Free Symbol: MANF Synonyms: ARMET; ARP Vector: pCMV6-XL5 E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: None Fully Sequenced ORF: >OriGene sequence for NM_006010 edited GGATGAGGAGGATGTGGGCCACGCAGGGGCTGGCGGTGGCGCTGGCTCTGAGCGTGCTGC CGGGCAGCCGGGCGCTGCGGCCGGGCGACTGCGAAGTTTGTATTTCTTATCTGGGAAGAT TTTACCAGGACCTCAAAGACAGAGATGTCACATTCTCACCAGCCACTATTGAAAACGAAC TTATAAAGTTCTGCCGGGAAGCAAGAGGCAAAGAGAATCGGTTGTGCTACTATATCGGGG CCACAGATGATGCAGCCACCAAAATCATCAATGAGGTATCAAAGCCTCTGGCCCACCACA TCCCTGTGGAGAAGATCTGTGAGAAGCTTAAGAAGAAGGACAGCCAGATATGTGAGCTTA AGTATGACAAGCAGATCGACCTGAGCACAGTGGACCTGAAGAAGCTCCGAGTTAAAGAGC TGAAGAAGATTCTGGATGACTGGGGGGAGACATGCAAAGGCTGTGCAGAAAAGTCTGACT ACATCCGGAAGATAAATGAACTGATGCCTAAATATGCCCCCAAGGCAGCCAGTGCACGGA CCGATTTGTAGTCTGCTCAATCTCTGTTGCACCTGAGGGGGAAAAAACAGTTCAACTGCT TACTCCCAAAACAGCCTTTTTGTAATTTATTTTTTAAGTGGGCTCCTGACAATACTGTAT CAGATGTGAAGCCTGGAGCTTTCCTGATGATGCTGGCCCTACAGTACCCCCATGAGGGGA TTCCCTTCCTTCTGTTGCTGGTGTACTCTAGGACTTCAAAGTGTGTCTGGGATTTTTTTA TTAAAGAAAAAAAATTTCTAGCTGTCCTTGCAGAATTATAGTGAATACCAAAATGGGGTT TTGCCCCAGGAGGCTCCTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online
    [Show full text]
  • Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Fall 2010 Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Renuka Nayak University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Computational Biology Commons, and the Genomics Commons Recommended Citation Nayak, Renuka, "Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress" (2010). Publicly Accessible Penn Dissertations. 1559. https://repository.upenn.edu/edissertations/1559 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1559 For more information, please contact [email protected]. Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Abstract Genes interact in networks to orchestrate cellular processes. Here, we used coexpression networks based on natural variation in gene expression to study the functions and interactions of human genes. We asked how these networks change in response to stress. First, we studied human coexpression networks at baseline. We constructed networks by identifying correlations in expression levels of 8.9 million gene pairs in immortalized B cells from 295 individuals comprising three independent samples. The resulting networks allowed us to infer interactions between biological processes. We used the network to predict the functions of poorly-characterized human genes, and provided some experimental support. Examining genes implicated in disease, we found that IFIH1, a diabetes susceptibility gene, interacts with YES1, which affects glucose transport. Genes predisposing to the same diseases are clustered non-randomly in the network, suggesting that the network may be used to identify candidate genes that influence disease susceptibility.
    [Show full text]
  • ARMET Polyclonal Antibody
    ARMET polyclonal antibody Catalog # : PAB13301 規格 : [ 100 ug ] List All Specification Application Image Product Rabbit polyclonal antibody raised against synthetic peptide of ARMET. Western Blot (Tissue lysate) Description: Immunogen: A synthetic peptide corresponding to C-terminus 12 amino acids of human ARMET. Host: Rabbit enlarge Reactivity: Human, Mouse, Rat Immunohistochemistry (Formalin/PFA-fixed paraffin- Form: Liquid embedded sections) Recommend Western Blot (1-2 ug/mL) Usage: The optimal working dilution should be determined by the end user. Storage Buffer: In PBS (0.02% sodium azide) enlarge Storage Store at 4°C for three months. For long term storage store at -20°C. Instruction: Aliquot to avoid repeated freezing and thawing. Note: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. Datasheet: Download Publication Reference 1. Role of IRE1α in podocyte proteostasis and mitochondrial health. José R Navarro-Betancourt, Joan Papillon, Julie Guillemette, Takao Iwawaki, Chen- Fang Chung, Andrey V Cybulsky.Cell Death Discov. 2020 Nov 19;6(1):128. doi: 10.1038/s41420-020-00361-4. 2. A soluble endoplasmic reticulum factor as regenerative therapy for Wolfram syndrome. Mahadevan J, Morikawa S, Yagi T, Abreu D, Lu S, Kanekura K, Brown CM, Urano F.Lab Invest. 2020 Sep;100(9):1197-1207. doi: 10.1038/s41374-020-0436-1. Epub 2020 May 4. 3. Mesencephalic Astrocyte-Derived Neurotrophic Factor as a Urine Biomarker for Endoplasmic Reticulum Stress-Related Kidney Diseases. Kim Y, Lee H, Manson SR, Lindahl M, Evans B, Miner JH, Urano F, Chen YM.J Am Soc Nephrol. 2016 Oct;27(10):2974-2982.
    [Show full text]